Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases

Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases

Abstract is missing (Short communication)

Bibliographic Details
Main Authors:	Sonja Braasch, Carsten Weishaupt, Eva Spukti, Markus Böhm, Stephan Alexander Braun
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2022-10-01
Series:	Acta Dermato-Venereologica
Subjects:	alopecia CTLA-4 immune-related adverse event PD-1
Online Access:	https://medicaljournalssweden.se/actadv/article/view/2311

Similar Items

Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
by: Elias A. T. Koch, et al.
Published: (2024-06-01)

The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
by: Lihu Gu, et al.
Published: (2019-06-01)

Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
by: Hanna Karhapää, et al.
Published: (2022-02-01)

Fluorouracil cream induced scarring alopecia after topical treatment of squamous cell carcinoma in situ
by: Christina I. Tejeda, MD, et al.
Published: (2021-09-01)

Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events
by: Davies M, et al.
Published: (2017-08-01)

Scarring alopecia and scalp pruritus
by: Catherine Barker, BS, et al.
Published: (2022-12-01)

Key questions about the checkpoint blockade-are microRNAs an answer?
by: Mihnea Dragomir, et al.
Published: (2018-06-01)

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
by: Maria Georganaki, et al.
Published: (2018-12-01)

Distinct autoantibody profiles across checkpoint inhibitor types and toxicities
by: Hong Mu-Mosley, et al.
Published: (2024-12-01)

Alopecia areata after mogamulizumab treatment
by: Neel S. Raval, BS, MPHS, et al.
Published: (2022-01-01)

Thyroid-related adverse events induced by immune checkpoint inhibitors
by: Alexandra Chera, et al.
Published: (2022-09-01)

Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
by: Yoshiyuki Nakamura
Published: (2019-05-01)

Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
by: Sarah Choe, et al.
Published: (2024-01-01)

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease
by: Hui Tang, et al.
Published: (2021-02-01)

Efficacy and safety of immune checkpoint blockade for brain metastases
by: Maya Harary, et al.
Published: (2019-06-01)

Prospects for combining immune checkpoint blockade with PARP inhibition
by: Anping Li, et al.
Published: (2019-09-01)

Cutaneous manifestations associated with immune checkpoint inhibitors
by: Tomoya Watanabe, et al.
Published: (2023-02-01)

Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions
by: Kimberly M. Winges, et al.
Published: (2022-11-01)

Achilles’ Heel of currently approved immune checkpoint inhibitors: immune related adverse events
by: Ting Yan, et al.
Published: (2024-02-01)

Pancreatic Adverse Events Associated With Immune Checkpoint Inhibitors: A Large-Scale Pharmacovigilance Analysis
by: Yue Zhang, et al.
Published: (2022-04-01)

Immune checkpoint blockade therapy in head and neck cancer: a review
by: Shajedul Islam, et al.
Published: (2018-12-01)

Immune checkpoint blockade therapy: The 2014 Tang prize in biopharmaceutical science
by: Ya-Shan Chen, et al.
Published: (2015-02-01)

Cardiac arrhythmias associated with immune checkpoint inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system
by: Feifei Wang, et al.
Published: (2022-11-01)

Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
by: Ming Yi, et al.
Published: (2019-03-01)

Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
by: Hao Wang, et al.
Published: (2019-06-01)

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review
by: Elizabeth S Mearns, et al.
Published: (2018-03-01)

Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
by: Rachel Sally, et al.
Published: (2024-03-01)

Combination approaches with immune checkpoint blockade in cancer therapy
by: Maarten Swart, et al.
Published: (2016-11-01)

TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
by: Matthew J. Reilley, et al.
Published: (2019-11-01)

Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy
by: Junghwa Lee, et al.
Published: (2023-07-01)

Central Nervous System Demyelination Associated With Immune Checkpoint Inhibitors: Review of the Literature
by: Marcos C. B. Oliveira, et al.
Published: (2020-12-01)

Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article
by: Chieh-Hsun Chen, et al.
Published: (2022-04-01)

Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Clinical and Radiological Profile and Response to Steroids
by: Anusha Shirwaikar Thomas, et al.
Published: (2024-01-01)

Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
by: Chi Yan, et al.
Published: (2021-11-01)

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
by: Gopalakrishnan D, et al.
Published: (2018-06-01)

Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
by: Ying Wang, et al.
Published: (2024-08-01)

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
by: Dia Roy, et al.
Published: (2023-10-01)

Immune checkpoint blockade impairs immunosuppressive mechanisms of regulatory T cells in B-cell lymphoma
by: Vera Bauer, et al.
Published: (2021-09-01)

Microcystic adnexal carcinoma simulating scarring alopecia
by: Maria Christina Marques Nogueira Castanon, et al.
Published: (2015-06-01)

Role of Hair Transplantation in Scarring Alopecia—To Do or Not to Do
by: Sukhbir Singh, et al.
Published: (2021-10-01)